FDA Approves Hepcludex as First Treatment for Chronic Hepatitis Delta Virus

The FDA approved Hepcludex (bulevirtide-gmod) injection for treating chronic HDV infection in adults without cirrhosis or with compensated cirrhosis. This marks the first FDA-approved treatment option for this serious liver condition.